Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level

G. Martinelli, E. Ottaviani, G. Visani, N. Testoni, V. Montefusco, S. Tura

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The characteristic t(15;17) translocation involving chromosomes 15 and 17 is specifically associated with both the common and the variant subtypes of acute promyelocytic leukemia (APL) (M3 according to FAB classification). At the molecular level, it fuses genes encoding PML on chromosome 15 and the nuclear retinoic acid receptor-α (RARα) on chromosome 17. The subsequent expression of PML/RARα fusion mRNA provides a potential molecular marker that can be detected in leukemic cells taken from patients with APL. Using PML and RARa sequence specific primers, reverse transcription-polymerase chain reaction (RT-PCR) assays have been developed for detection of PML/RARα transcript in leukemic cells obtained from patients; these RT-PCR assays are more sensitive than conventional cytogenetic analysis.

Original languageEnglish
Pages (from-to)860-863
Number of pages4
JournalHaematologica
Volume83
Issue number9
Publication statusPublished - 1998

Fingerprint

Acute Promyelocytic Leukemia
Retinoic Acid Receptors
Chromosomes, Human, Pair 15
Chromosomes, Human, Pair 17
Reverse Transcription
Polymerase Chain Reaction
Cytogenetic Analysis
Messenger RNA
Genes

ASJC Scopus subject areas

  • Hematology

Cite this

Martinelli, G., Ottaviani, E., Visani, G., Testoni, N., Montefusco, V., & Tura, S. (1998). Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level. Haematologica, 83(9), 860-863.

Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level. / Martinelli, G.; Ottaviani, E.; Visani, G.; Testoni, N.; Montefusco, V.; Tura, S.

In: Haematologica, Vol. 83, No. 9, 1998, p. 860-863.

Research output: Contribution to journalArticle

Martinelli, G, Ottaviani, E, Visani, G, Testoni, N, Montefusco, V & Tura, S 1998, 'Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level', Haematologica, vol. 83, no. 9, pp. 860-863.
Martinelli, G. ; Ottaviani, E. ; Visani, G. ; Testoni, N. ; Montefusco, V. ; Tura, S. / Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level. In: Haematologica. 1998 ; Vol. 83, No. 9. pp. 860-863.
@article{0473354058e047008f8e6c00fd4fd23d,
title = "Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level",
abstract = "The characteristic t(15;17) translocation involving chromosomes 15 and 17 is specifically associated with both the common and the variant subtypes of acute promyelocytic leukemia (APL) (M3 according to FAB classification). At the molecular level, it fuses genes encoding PML on chromosome 15 and the nuclear retinoic acid receptor-α (RARα) on chromosome 17. The subsequent expression of PML/RARα fusion mRNA provides a potential molecular marker that can be detected in leukemic cells taken from patients with APL. Using PML and RARa sequence specific primers, reverse transcription-polymerase chain reaction (RT-PCR) assays have been developed for detection of PML/RARα transcript in leukemic cells obtained from patients; these RT-PCR assays are more sensitive than conventional cytogenetic analysis.",
author = "G. Martinelli and E. Ottaviani and G. Visani and N. Testoni and V. Montefusco and S. Tura",
year = "1998",
language = "English",
volume = "83",
pages = "860--863",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "9",

}

TY - JOUR

T1 - Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level

AU - Martinelli, G.

AU - Ottaviani, E.

AU - Visani, G.

AU - Testoni, N.

AU - Montefusco, V.

AU - Tura, S.

PY - 1998

Y1 - 1998

N2 - The characteristic t(15;17) translocation involving chromosomes 15 and 17 is specifically associated with both the common and the variant subtypes of acute promyelocytic leukemia (APL) (M3 according to FAB classification). At the molecular level, it fuses genes encoding PML on chromosome 15 and the nuclear retinoic acid receptor-α (RARα) on chromosome 17. The subsequent expression of PML/RARα fusion mRNA provides a potential molecular marker that can be detected in leukemic cells taken from patients with APL. Using PML and RARa sequence specific primers, reverse transcription-polymerase chain reaction (RT-PCR) assays have been developed for detection of PML/RARα transcript in leukemic cells obtained from patients; these RT-PCR assays are more sensitive than conventional cytogenetic analysis.

AB - The characteristic t(15;17) translocation involving chromosomes 15 and 17 is specifically associated with both the common and the variant subtypes of acute promyelocytic leukemia (APL) (M3 according to FAB classification). At the molecular level, it fuses genes encoding PML on chromosome 15 and the nuclear retinoic acid receptor-α (RARα) on chromosome 17. The subsequent expression of PML/RARα fusion mRNA provides a potential molecular marker that can be detected in leukemic cells taken from patients with APL. Using PML and RARa sequence specific primers, reverse transcription-polymerase chain reaction (RT-PCR) assays have been developed for detection of PML/RARα transcript in leukemic cells obtained from patients; these RT-PCR assays are more sensitive than conventional cytogenetic analysis.

UR - http://www.scopus.com/inward/record.url?scp=0031790807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031790807&partnerID=8YFLogxK

M3 - Article

C2 - 9825588

AN - SCOPUS:0031790807

VL - 83

SP - 860

EP - 863

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 9

ER -